1. Home
  2. ATS vs MLTX Comparison

ATS vs MLTX Comparison

Compare ATS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATS
  • MLTX
  • Stock Information
  • Founded
  • ATS 1978
  • MLTX 2021
  • Country
  • ATS Canada
  • MLTX Switzerland
  • Employees
  • ATS N/A
  • MLTX N/A
  • Industry
  • ATS
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATS
  • MLTX Health Care
  • Exchange
  • ATS Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • ATS 2.7B
  • MLTX 2.4B
  • IPO Year
  • ATS 2023
  • MLTX N/A
  • Fundamental
  • Price
  • ATS $28.77
  • MLTX $39.42
  • Analyst Decision
  • ATS Sell
  • MLTX Strong Buy
  • Analyst Count
  • ATS 2
  • MLTX 8
  • Target Price
  • ATS $30.50
  • MLTX $77.71
  • AVG Volume (30 Days)
  • ATS 153.1K
  • MLTX 301.3K
  • Earning Date
  • ATS 05-28-2025
  • MLTX 05-12-2025
  • Dividend Yield
  • ATS N/A
  • MLTX N/A
  • EPS Growth
  • ATS N/A
  • MLTX N/A
  • EPS
  • ATS N/A
  • MLTX N/A
  • Revenue
  • ATS $1,762,471,214.00
  • MLTX N/A
  • Revenue This Year
  • ATS N/A
  • MLTX $103.42
  • Revenue Next Year
  • ATS $13.22
  • MLTX N/A
  • P/E Ratio
  • ATS N/A
  • MLTX N/A
  • Revenue Growth
  • ATS N/A
  • MLTX N/A
  • 52 Week Low
  • ATS $20.90
  • MLTX $31.42
  • 52 Week High
  • ATS $34.32
  • MLTX $58.26
  • Technical
  • Relative Strength Index (RSI)
  • ATS 54.97
  • MLTX 52.61
  • Support Level
  • ATS $27.68
  • MLTX $37.80
  • Resistance Level
  • ATS $30.68
  • MLTX $40.71
  • Average True Range (ATR)
  • ATS 1.09
  • MLTX 1.72
  • MACD
  • ATS 0.16
  • MLTX 0.04
  • Stochastic Oscillator
  • ATS 48.55
  • MLTX 68.51

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: